bluebird bio Inc.

(BLUE) Trade

By |

Profile

bluebird bio Inc is a clinical-stage biotechnology company which develops gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy.

Contact Information

Website: www.bluebirdbio.com
Email: investor@bluebirdbio.com
Main Phone: +1 339 499-9300
Address: 60 Binney Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
CEO: Nick Leschly
Employees: 479
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
$ 180.60 $ 0.30 (0.17%)
Last Price 180.60 Change $ 0.30 Change % 0.17 Tick N/A
Bid 178.00 Bid Size 200.00 Ask 183.00 Ask Size 100.00
Open 180.95 High 183.00 Low 178.60 Prev Close 180.30
Last Trade Volume 491,560 52 Wk Hi 236.17 52 Wk Low 85.65
Market Cap 9.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 50,119,272.00 EPS (TTM) -8.34 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 47 288
Number of Buys 8 76
Number of Sells 39 212
Net Activity -4750 -143255
Last 10 Buys Shares
Nick Leschly 1,000
Nick Leschly 1,000
John M. Maraganore 1,000
David P. Schenkein 1,000
John M. Maraganore 1,000
Last 10 Sell Shares
Susanna High 1,000
David Davidson 1,000
David Davidson 1,000
David Davidson 1,000
David Davidson 1,000
David Davidson 1,000
Mark Vachon 1,000
Mark Vachon 1,000
Mark Vachon 1,000
David Davidson 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 242 242 242 242
Low Target Price Estimate 122 122 122 122
Mean Target Price Estimate 204.24 202 202 204.24
Standard Deviation 32.59 32.29 32.29 32.59
Date of Most Recent Estimate 06/05/18 05/22/18 05/22/18 06/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 13 12 12 12
Moderate Buy 0 0 0 0
Hold 6 6 6 7
Moderate Sell 0 0 0 0
Strong Sell 1 0 1 1
Mean Rec. 1.8 1.67 1.84 1.9